Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
15/04/2026 01:34
April 15 (Reuters) - Mesoblast Ltd MSB.AX: MESOBLAST LTD-ACQUIRES CAR PLATFORM FOR PRECISION-ENHANCED CELL PRODUCTS ACQUIRES CAR PLATFORM FOR PRECISION-ENHANCED CELL PRODUCTS-MSB.AX TO INCORPORATE ENGINEERED CARS TO ENHANCE PRODUCT SPECIFICITY OBTAINS WORLDWIDE EXCLUSIVE RIGHTS TO CAR-MSC IP FROM MAYO CLINIC MAYO CLINIC TO PROVIDE IN-KIND SUPPORT AND GMP MANUFACTURING FOR CAR-MSC TECHNOLOGY Further company coverage: MSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast Reports QTRLY Ryoncil Net Revenues Of $30.3 Million
ASX-shares of Mesoblast rise after back-treatment drug hits patent target
Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech
Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
Brief: Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M